CellMax Life vs SAGA Diagnostics

CellMax Life logo

CellMax Life

Liquid biopsy company focused on cancer screening with a proprietary platform for detecting precancer and cancer cells

25 employees · est. 2013 · Sunnyvale, United States

VS
SAGA Diagnostics logo

SAGA Diagnostics

Redefining the early detection of molecular residual disease (MRD)

97 employees · est. 2016 · Morrisville, United States

CellMax Life is the older company (2013 vs 2016); SAGA Diagnostics is the larger of the two.

Side-by-Side Comparison

CellMax Life SAGA Diagnostics
Founded
2013 older 2016
Headquarters
Sunnyvale, United States Morrisville, United States
Employees
25 97 larger
Industry
Biotechnology, Health Care Biotechnology
Funding Stage
Not tracked yet Series A
Total Funding
$14.00M $15.25M
Funding Rounds
3 6
Services
development of non-invasive blood tests for cancer detection, colorectal cancer screening and prevention, adenoma detection technology Molecular residual disease diagnostics, Pathlight MRD platform, Whole-genome sequencing, Customized digital PCR assays
Target Customers
individuals recommended for routine cancer screening, healthcare providers offering cancer prevention services Clinicians, Healthcare providers, Biopharma companies, Cancer patients (especially in early stages)
Taxonomy
Liquid BiopsyCancer ScreeningPrecision MedicineEarly Cancer DetectionNon-invasive TestsCirculating Tumor Cell +6 Personalized Cancer MedicineDisease MonitoringCirculating Tumor DNALiquid BiopsyMolecular Genetic AnalysesPrecision Oncology +9
Website
cellmaxlife.com sagadiagnostics.com
CellMax Life logo

About CellMax Life

CellMax Life, founded in 2013, is positioned at the forefront of the biotechnology and health care industries with its innovative focus on liquid biopsy technology for cancer screening. Their proprietary platform is tailored to detect pre-cancer and cancer cells, disrupting traditional diagnostic pa...

SAGA Diagnostics logo

About SAGA Diagnostics

SAGA Diagnostics, founded in 2016, is making significant strides in the biotechnology industry by focusing on personalized cancer medicine. Their unique approach centers on molecular genetic analyses of circulating tumor DNA and tissue biopsies, aiming to revolutionize the early detection of molecul...

Also comparing in this category

Comparing more than these two?

Get CellMax Life, SAGA Diagnostics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does CellMax Life compare?

A PDF of CellMax Life and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

CellMax Life was founded in 2013, based in Sunnyvale, United States, with 25 employees. CellMax Life, founded in 2013, is positioned at the forefront of the biotechnology and health care industries with its innovative focus on liquid biopsy technology for cancer screening. Their propriet. SAGA Diagnostics was founded in 2016, based in Morrisville, United States, with 97 employees. SAGA Diagnostics, founded in 2016, is making significant strides in the biotechnology industry by focusing on personalized cancer medicine. Their unique approach centers on molecular genetic analyses.
CellMax Life has raised $14.00M and SAGA Diagnostics $15.25M. Latest stage: SAGA Diagnostics Series A.
Both work in Biotechnology and list liquid biopsy and cancer diagnostics among their focus areas.

Compare CellMax Life with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CellMax Life on 12 Sep 2024, and SAGA Diagnostics on 23 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes